Medtronic Stock Jumps On Heart-Device Beat, But One 2027 Warning Hangs Over Rally
Medtronic plc shares jumped on Wednesday after the medical-device maker beat Wall Street’s fiscal fourth-quarter sales and profit estimates, helped by demand for heart devices used in complex cardiac procedures. The stock was recently up 5.1% at $77.52, outpacing a 0.6% rise in the iShares U.S. Medical Devices ETF.